Fyfe J A, McCowan C, O'Brien C R, Globan M, Birch C, Revill P, Barrs V R D, Wayne J, Hughes M S, Holloway S, Malik R
Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn St., North Melbourne, Victoria, Australia 3051.
J Clin Microbiol. 2008 Feb;46(2):618-26. doi: 10.1128/JCM.01186-07. Epub 2007 Dec 5.
Between 1999 and 2006, 15 cats were diagnosed with disease attributable to a novel mycobacterial species. The infections consisted of granulomatous lesions in the skin, subcutis, and ocular or periocular tissues with an indolent but progressive clinical course. Lesions typically were found in facial regions or on the distal limbs. Cats of all ages and both sexes were affected. Infections often were challenging to treat, although they could be cured using surgery in concert with combination antimicrobial therapy. Microscopically, lesions were granulomatous to pyogranulomatous and contained numerous acid-fast bacilli. Scanty cultures of the causal microorganisms occasionally could be obtained in mycobacterial broth, but subculture to solid media failed. When cultures were not available, DNA was extracted from fresh tissue, lyophilized material, and formalin-fixed, paraffin-embedded tissues from lesions. PCR amplification of the 5' end of the 16S rRNA gene and regions within four additional loci (ITS1, hsp65, rpoB, and sodA) was performed with various efficiencies using mycobacterial primers. Nucleotide sequences were unique for each locus tested. Nucleotide sequences obtained from individual cases were identical for each locus for which the amplification was successful. Phylogenetic analysis performed using concatenated partial 16S rRNA and hsp65 gene sequences indicated that this novel mycobacterial species from Victoria is a member of the Mycobacterium simiae-related group, taxonomically related to the mycobacterium causing leproid granulomas in dogs throughout the world. Based on the clustering of cases, we refer to this novel species as Mycobacterium sp. strain Tarwin.
1999年至2006年间,15只猫被诊断患有由一种新型分枝杆菌引起的疾病。感染表现为皮肤、皮下组织以及眼或眼周组织出现肉芽肿性病变,临床病程缓慢但呈进行性发展。病变通常见于面部区域或四肢末端。所有年龄和性别的猫均受影响。尽管通过手术联合抗菌治疗可以治愈,但感染往往难以治疗。显微镜下,病变为肉芽肿性至脓性肉芽肿性,含有大量抗酸杆菌。偶尔可在分枝杆菌肉汤中获得少量致病微生物培养物,但转种至固体培养基则失败。当无法获得培养物时,从新鲜组织、冻干材料以及病变部位的福尔马林固定石蜡包埋组织中提取DNA。使用分枝杆菌引物对16S rRNA基因5'端以及另外四个位点(ITS1、hsp65、rpoB和sodA)内的区域进行PCR扩增,扩增效率各不相同。每个检测位点的核苷酸序列都是独特的。从各个病例获得的核苷酸序列在每个成功扩增的位点上都是相同的。使用串联的部分16S rRNA和hsp65基因序列进行系统发育分析表明,来自维多利亚州的这种新型分枝杆菌是猿分枝杆菌相关菌群的成员,在分类学上与世界各地引起犬类类麻风肉芽肿的分枝杆菌有关。基于病例的聚类情况,我们将这种新物种称为塔文分枝杆菌菌株(Mycobacterium sp. strain Tarwin)。